IKS03 clinical trials

IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

This study is testing a new medicine, IKS03, for people with certain types of advanced B-cell non-Hodgkin lymphoma. It aims to find the safest dose and see how well it works. This is an early-stage study, meaning it's the first time it’s being given to people.